Chun Yu Pan

Director/Board Member at UWELL Biopharma, Inc.

Health Technology

Consumer Services

Transportation

Profile

Chun Yu Pan currently works at UWELL Biopharma, Inc., as Director.
Mr. Pan also formerly worked at Shangya Technology Co., Ltd., as Director-Supervisory Board and Vectorite Biomedical, Inc., as Director from 2011 to 2014.
Mr. Pan received his Masters Business Admin degree from Chinese Culture University.

Chun Yu Pan active positions

Companies	Position	Start
UWELL Biopharma, Inc. UWELL Biopharma, Inc. Pharmaceuticals: MajorHealth Technology UWELL Biopharma, Inc. is a biotech company founded in 2003 and based in New Taipei, Taiwan. The Taiwanese company specializes in developing new cancer drugs using chimeric antigen receptor T-cell (CAR-T) technology. CAR-T therapy involves engineering a patient's T-cells to recognize and attack cancer cells. UWELL is currently conducting an open, single-center phase I clinical trial to evaluate the safety and efficacy of its anti-CD19 CAR-T cell injection in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma. The study has been approved by the Institutional Review Board of Tri-Service General Hospital and the Ministry of Health and Welfare. UWELL has achieved success in treating adult blood cancer patients with CAR-T therapy, as evidenced by the clearance of cancer cells in the first case treated at Tri-Service General Hospital.	Director/Board Member	-

All active positions of Chun Yu Pan

Former positions of Chun Yu Pan

Companies	Position	End
VECTORITE BIOMEDICAL INC.	Director/Board Member	-
SHANGYA TECHNOLOGY CO., LTD.	Director/Board Member	-

See the detail of Chun Yu Pan's experience

Training of Chun Yu Pan

Chinese Culture University

Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Chun Yu Pan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
SHANGYA TECHNOLOGY CO., LTD.	Health Technology
VECTORITE BIOMEDICAL INC.	Transportation

Private companies	1
UWELL Biopharma, Inc. UWELL Biopharma, Inc. Pharmaceuticals: MajorHealth Technology UWELL Biopharma, Inc. is a biotech company founded in 2003 and based in New Taipei, Taiwan. The Taiwanese company specializes in developing new cancer drugs using chimeric antigen receptor T-cell (CAR-T) technology. CAR-T therapy involves engineering a patient's T-cells to recognize and attack cancer cells. UWELL is currently conducting an open, single-center phase I clinical trial to evaluate the safety and efficacy of its anti-CD19 CAR-T cell injection in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma. The study has been approved by the Institutional Review Board of Tri-Service General Hospital and the Ministry of Health and Welfare. UWELL has achieved success in treating adult blood cancer patients with CAR-T therapy, as evidenced by the clearance of cancer cells in the first case treated at Tri-Service General Hospital.	Health Technology